How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Mouse and Touchpads not only make computing easy but more efficient and less time-consuming. We cannot imagine a life without these devices, but still, it is a fact that you cannot customize these ...

Many physicists consider Ed Witten to be Einstein's true successor. A mathematical physicist at the Institute for Advanced Study in Princeton, New Jersey, Witten has been awarded everything from a ...